Abstract
Background
The outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) depends on the extent of peritoneal metastases (PM) and the completeness of cytoreduction (CCR). The role of preoperative assessment of PM is to identify potential candidates for CRS/HIPEC and to prevent unwarranted laparotomy for those who are not. Laparoscopy has been utilized for that purpose but with concerns related to technical difficulties and risk of trocar site metastases. Single-incision laparoscopic peritoneal exploration (SILPE) has not yet been evaluated in this setting.
Methods
This single-center retrospective study examined patients from January 2011 to December 2015 who underwent SILPE for diagnosis and staging of PM. Preoperative, intraoperative, and postoperative data were collected. For the patients who underwent subsequent laparotomy, a comparison between SILPE and laparotomy findings was made.
Results
A total of 183 SILPE were performed. Primary sites were mostly colorectal in 72 cases (39.3%) and gastric in 47 (25.7%). Overall, 157 patients (85.8%) had at least one prior abdominal surgery and 48 (26.2%) had 3 or more. SILPE was successfully achieved in 90.2% of the cases. Two (1.2%) intraoperative complications and five (3%) postoperative complications were observed. Eighty-one patients had laparotomy, with a median of 27 days between SILPE and laparotomy (4–162 days). The peritoneal carcinomatosis index PCI was 9.7 ± 7.5 at SILPE, and 13.5 ± 9.6 at laparotomy. The positive predictive value of SILPE to predict CCR was 79.5%. SILPE sensitivity was 75% and specificity 97%. The lowest sensitivity was in regions 9–12 ranging from 44 to 53%.
Conclusion
SILPE can be safely incorporated in the management of patients with PM. It is a safe and feasible staging tool, allowing for preventing unwarranted laparotomy for patients not deemed candidate for CRS/HIPEC. Even though it may underestimate PCI, SILPE accurately predicts the possibility of CCR.
Similar content being viewed by others
References
Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FAN (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737–3743. https://doi.org/10.1200/JCO.2003.04.187
Goéré D, Malka D, Tzanis D, Gava V, Boige V, Eveno C, Maggiori L, Dumont F, Ducreux M, Elias D (2013) Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg 257:1065–1071. https://doi.org/10.1097/SLA.0b013e31827e9289
Elias D, Gilly F, Boutitie F, Quenet F, Bereder J-M, Mansvelt B, Lorimier G, Dubè P, Glehen O (2010) Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 28:63–68. https://doi.org/10.1200/JCO.2009.23.9285
Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H (2008) 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2426–2432. https://doi.org/10.1245/s10434-008-9966-2
van Driel WJ, Koole SN, Sonke GS (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 378:1363–1364. https://doi.org/10.1056/NEJMc1802033
Tabrizian P, Shrager B, Jibara G, Yang M-J, Romanoff A, Hiotis S, Sarpel U, Labow DM (2014) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution. J Gastrointest Surg 18:1024–1031. https://doi.org/10.1007/s11605-014-2477-5
Chua TC, Saxena A, Schellekens JF, Liauw W, Yan TD, Fransi S, Zhao J, Morris DL (2010) Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: towards a new perspective of this treatment. Ann Surg 251:101–106. https://doi.org/10.1097/SLA.0b013e3181b5ae43
Jafari MD, Halabi WJ, Stamos MJ, Nguyen VQ, Carmichael JC, Mills SD, Pigazzi A (2014) Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the american college of surgeons national surgical quality improvement program. JAMA Surg 149:170–175. https://doi.org/10.1001/jamasurg.2013.3640
Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–374
Cotte E, Passot G, Gilly F-N, Glehen O (2010) Selection of patients and staging of peritoneal surface malignancies. World J Gastrointest Oncol 2:31–35. https://doi.org/10.4251/wjgo.v2.i1.31
Esquivel J, Sticca R, Sugarbaker P, Levine E, Yan TD, Alexander R, Baratti D, Bartlett D, Barone R, Barrios P, Bieligk S, Bretcha-Boix P, Chang CK, Chu F, Chu Q, Daniel S, de Bree E, Deraco M, Dominguez-Parra L, Elias D, Flynn R, Foster J, Garofalo A, Gilly FN, Glehen O, Gomez-Portilla A, Gonzalez-Bayon L, Gonzalez-Moreno S, Goodman M, Gushchin V, Hanna N, Hartmann J, Harrison L, Hoefer R, Kane J, Kecmanovic D, Kelley S, Kuhn J, Lamont J, Lange J, Li B, Loggie B, Mahteme H, Mann G, Martin R, Misih RA, Moran B, Morris D, Onate-Ocana L, Petrelli N, Philippe G, Pingpank J, Pitroff A, Piso P, Quinones M, Riley L, Rutstein L, Saha S, Alrawi S, Sardi A, Schneebaum S, Shen P, Shibata D, Spellman J, Stojadinovic A, Stewart J, Torres-Melero J, Tuttle T, Verwaal V, Villar J, Wilkinson N, Younan R, Zeh H, Zoetmulder F, Sebbag G, Society of Surgical Oncology Annual Meeting (2007) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol 14:128–133. https://doi.org/10.1245/s10434-006-9185-7
Yan TD, Morris DL, Shigeki K, Dario B, Marcello D (2008) Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy: expert consensus statement. J Surg Oncol 98:224–227. https://doi.org/10.1002/jso.21069
Angelelli G, Ianora AA, Scardapane A, Pedote P, Memeo M, Rotondo A (2001) Role of computerized tomography in the staging of gastrointestinal neoplasms. Semin Surg Oncol 20:109–121
de Bree E, Koops W, Kröger R, van Ruth S, Verwaal VJ, Zoetmulder FAN (2006) Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 32:65–71. https://doi.org/10.1016/j.ejso.2005.09.016
Pfannenberg C, Königsrainer I, Aschoff P, Oksüz MO, Zieker D, Beckert S, Symons S, Nieselt K, Glatzle J, Weyhern CV, Brücher BL, Claussen CD, Königsrainer A (2009) (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 16:1295–1303. https://doi.org/10.1245/s10434-009-0387-7
Audollent R, Eveno C, Dohan A, Sarda L, Jouvin I, Soyer P, Pocard M (2015) Pitfalls and mimickers on (18)F-FDG-PET/CT in peritoneal carcinomatosis from colorectal cancer: an analysis from 37 patients. J Visc Surg 152:285–291. https://doi.org/10.1016/j.jviscsurg.2015.06.003
Menassel B, Duclos A, Passot G, Dohan A, Payet C, Isaac S, Valette PJ, Glehen O, Rousset P (2016) Preoperative CT and MRI prediction of non-resectability in patients treated for pseudomyxoma peritonei from mucinous appendiceal neoplasms. Eur J Surg Oncol 42:558–566. https://doi.org/10.1016/j.ejso.2016.01.005
Dohan A, Hobeika C, Najah H, Pocard M, Rousset P, Eveno C (2018) Preoperative assessment of peritoneal carcinomatosis of colorectal origin. J Visc Surg 155:293–303. https://doi.org/10.1016/j.jviscsurg.2018.01.002
Elias D, Honoré C, Dumont F, Ducreux M, Boige V, Malka D, Burtin P, Dromain C, Goéré D (2011) Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 254:289–293. https://doi.org/10.1097/SLA.0b013e31822638f6
Pomel C, Appleyard T-L, Gouy S, Rouzier R, Elias D (2005) The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 31:540–543. https://doi.org/10.1016/j.ejso.2005.01.009
van Oudheusden TR, Braam HJ, Luyer MDP, Wiezer MJ, van Ramshorst B, Nienhuijs SW, de Hingh IHJT (2015) Peritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: risk factors, treatment options, and prognosis. Ann Surg Oncol 22:1236–1242. https://doi.org/10.1245/s10434-014-4148-x
Iversen LH, Rasmussen PC, Laurberg S (2013) Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Br J Surg 100:285–292. https://doi.org/10.1002/bjs.8908
Jayakrishnan TT, Zacharias AJ, Sharma A, Pappas SG, Gamblin TC, Turaga KK (2014) Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). World J Surg Oncol 12:270. https://doi.org/10.1186/1477-7819-12-270
Laterza B, Kusamura S, Baratti D, Oliva GD, Deraco M (2009) Role of explorative laparoscopy to evaluate optimal candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal mesothelioma. In Vivo 23:187–190
Marmor RA, Kelly KJ, Lowy AM, Baumgartner JM (2016) Laparoscopy is safe and accurate to evaluate peritoneal surface metastasis prior to cytoreductive surgery. Ann Surg Oncol 23:1461–1467. https://doi.org/10.1245/s10434-015-4958-5
Nunez MF, Sardi A, Jimenez W, Nieroda C, Sittig M, MacDonald R, Aydin N, Milovanov V, Gushchin V (2015) Port-site metastases is an independent prognostic factor in patients with peritoneal carcinomatosis. Ann Surg Oncol 22:1267–1273. https://doi.org/10.1245/s10434-014-4136-1
Nunez MF, Sardi A, Nieroda C, Jimenez W, Sittig M, MacDonald R, Aydin N, Milovanov V, Gushchin V (2015) Morbidity of the abdominal wall resection and reconstruction after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Ann Surg Oncol 22:1658–1663. https://doi.org/10.1245/s10434-014-4075-x
Hobeika C, Sabbagh C, Najah H, Eveno C (2017) Laparoscopic exploration for peritoneal carcinomatosis: surgical technique. J Visc Surg 154:430–435. https://doi.org/10.1016/j.jviscsurg.2017.08.005
Pocard M (2015) Exploratory laparoscopy for carcinomatosis: discard that quiver full of trocars and use just one! J Visc Surg 152:147–148. https://doi.org/10.1016/j.jviscsurg.2015.04.004
Najah H, Lo Dico R, Eveno C, Pocard M (2017) Laparo-endoscopic single site surgery for peritoneal carcinomatosis detection and staging (with video). J Visc Surg 154:133–134. https://doi.org/10.1016/j.jviscsurg.2017.03.001
Najah H, Lo Dico R, Grienay M, Dohan A, Dray X, Pocard M (2016) Single-incision flexible endoscopy (SIFE) for detection and staging of peritoneal carcinomatosis. Surg Endosc 30:3808–3815. https://doi.org/10.1007/s00464-015-4682-z
Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
Tabrizian P, Jayakrishnan TT, Zacharias A, Aycart S, Johnston FM, Sarpel U, Labow DM, Turaga KK (2015) Incorporation of diagnostic laparoscopy in the management algorithm for patients with peritoneal metastases: a multi-institutional analysis. J Surg Oncol 111:1035–1040. https://doi.org/10.1002/jso.23924
Passot G, Dumont F, Goéré D, Arvieux C, Rousset P, Regimbeau J-M, Elias D, Villeneuve L, Glehen O, BIG-RENAPE Surgery Working Group (2018) Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE). Br J Surg 105:663–667. https://doi.org/10.1002/bjs.10723
Sommariva A, Zagonel V, Rossi CR (2012) The role of laparoscopy in peritoneal surface malignancies selected for hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 19:3737–3744. https://doi.org/10.1245/s10434-012-2465-5
Liberale G, Vankerckhove S, Caldon MG, Ahmed B, Moreau M, Nakadi IE, Larsimont D, Donckier V, Bourgeois P, Group R&D for the Clinical Application of Fluorescence Imaging of the Jules Bordetʼs Institute (2016) Fluorescence imaging after indocyanine green injection for detection of peritoneal metastases in patients undergoing cytoreductive surgery for peritoneal carcinomatosis from colorectal cancer: a pilot study. Ann Surg 264:1110–1115. https://doi.org/10.1097/SLA.0000000000001618
Najah H, Lo Dico R, Dohan A, Marry L, Eveno C, Pocard M (2017) A feasibility study of the use of computed virtual chromoendoscopy for laparoscopic evaluation of peritoneal metastases. Surg Endosc 31:743–751. https://doi.org/10.1007/s00464-016-5028-1
Najah H, Jouvin I, Besbes S, Cifuentes D, Eveno C, Pocard M (2017) Specific computed virtual chromoendoscopy for detection of peritoneal carcinomatosis: an animal study. Surg Endosc 31:4034–4043. https://doi.org/10.1007/s00464-017-5442-z
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Fujifilm Medical System Company has lent the INSERM 965 Research Unit (attached to the department of Surgery of Lariboisière Hospital) a gastroscope and a FICE system in order to study the contribution of virtual chromoendoscopy to detect peritoneal carcinomatosis in animal model. Drs. Haythem Najah and Marc Pocard had recently filed a patent via INSERMTransfert in Europe and in the USA. Drs. Brice Malgras, Anthony Dohan, Caroline Gronnier, and Clarisse Eveno have no conflicts of interest or financial ties to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Najah, H., Malgras, B., Dohan, A. et al. The role of single-incision laparoscopic peritoneal exploration in the management of patients with peritoneal metastases. Surg Endosc 34, 2040–2049 (2020). https://doi.org/10.1007/s00464-019-06984-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-019-06984-8